Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Zoetis Inc.ZTS · Entity 679 | Executive Vice President | October 09, 2026 | October 14, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Zoetis Inc.
Report date October 09, 2026 · Filed October 14, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Phantom Stock UnitSEC Table II · derivative / convertible security | Direct | 31,314.6485 |
Reported balance
After 2026-10-09 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2026-10-09 · Grant · Acquired 367.7875 · Balance 31,314.6485 F1: These phantom stock units, which were acquired pursuant to the Zoetis Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment fund at any time, provided Zoetis may limit the timing, frequency and permissibility of transfers from one investment fund to another at any time. F2: Each phantom stock unit represents a fraction of a phantom share of Zoetis common stock, plus a small amount of cash-equivalent investments (the cash-equivalent investments typically represent around 5% of the total value of the phantom stock unit). Accordingly, the value of each phantom stock unit is determined by reference to the market value of Zoetis common stock and the value of the cash-equivalent investments. |
Filing footnotes · ownership attribution and instrument terms
F1: These phantom stock units, which were acquired pursuant to the Zoetis Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment fund at any time, provided Zoetis may limit the timing, frequency and permissibility of transfers from one investment fund to another at any time.
F2: Each phantom stock unit represents a fraction of a phantom share of Zoetis common stock, plus a small amount of cash-equivalent investments (the cash-equivalent investments typically represent around 5% of the total value of the phantom stock unit). Accordingly, the value of each phantom stock unit is determined by reference to the market value of Zoetis common stock and the value of the cash-equivalent investments.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| February 10, 2024 Filed Feb 13, 2024 22:07 UTC | Zoetis Inc. ZTS · Entity 679 | Exercise / conversionCommon Stock | 1,710 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001555280-24-000165 · wk-form4_1707862061.xml · nonDerivative · entry 1 Lagano Roxanne · CIK 0001567878 · Executive Vice President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 19,642 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Acquisition of common stock upon vesting and settlement of restricted stock units (RSUs). Each RSU represents a right to receive one share of Zoetis Inc. common stock upon vesting of the RSU. Read SEC document |
| February 08, 2024 Filed Feb 12, 2024 22:53 UTC | Zoetis Inc. ZTS · Entity 679 | Exercise / conversionRestricted Stock Unit · Derivative | 591.7569 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001555280-24-000123 · wk-form4_1707778413.xml · derivative · entry 4 Lagano Roxanne · CIK 0001567878 · Executive Vice President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,182 Underlying: Common Stock · 591.7569 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · security: Represents restricted stock units granted pursuant to the Zoetis Inc. Amended and Restated 2013 Equity and Incentive Plan, and dividend equivalent units automatically issued thereon (each an "RSU" and collectively, "RSUs"). F4 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of Zoetis Inc. common stock. F1 · price: Acquisition of common stock upon vesting and settlement of restricted stock units (RSUs). Each RSU represents a right to receive one share of Zoetis Inc. common stock upon vesting of the RSU. F5 · derivative.exercise_date: One-third of each RSU will vest and be settled in shares of Zoetis Inc. common stock on the first, second and third anniversaries of the date of grant, February 8, 2023; subject to the reporting person's continued service through such vesting date and subject to earlier vesting and settlement upon certain specific events. F6 · derivative.expiration_date: Not applicable. Read SEC document |
| February 08, 2024 Filed Feb 12, 2024 22:53 UTC | Zoetis Inc. ZTS · Entity 679 | Tax withholdingCommon Stock | 228 | $195.75 | $44,631.00 |
DisclosureSEC source: 0001555280-24-000123 · wk-form4_1707778413.xml · nonDerivative · entry 2 Lagano Roxanne · CIK 0001567878 · Executive Vice President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 17,932 Read SEC document |
| February 08, 2024 Filed Feb 12, 2024 22:53 UTC | Zoetis Inc. ZTS · Entity 679 | Exercise / conversionCommon Stock | 591 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001555280-24-000123 · wk-form4_1707778413.xml · nonDerivative · entry 1 Lagano Roxanne · CIK 0001567878 · Executive Vice President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 18,160 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: Acquisition of common stock upon vesting and settlement of restricted stock units (RSUs). Each RSU represents a right to receive one share of Zoetis Inc. common stock upon vesting of the RSU. F1 · price: Acquisition of common stock upon vesting and settlement of restricted stock units (RSUs). Each RSU represents a right to receive one share of Zoetis Inc. common stock upon vesting of the RSU. Read SEC document |
| February 06, 2024 Filed Feb 8, 2024 21:33 UTC | Zoetis Inc. ZTS · Entity 679 | GrantStock Option · Derivative | 6,127 | $0.00 Strike: $196.14 | $0.00 |
DisclosureSEC source: 0001555280-24-000077 · wk-form4_1707428006.xml · derivative · entry 4 Lagano Roxanne · CIK 0001567878 · Executive Vice President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,127 Underlying: Common Stock · 6,127 shares Expires not disclosed F8 · security: Stock options (right to buy Zoetis Inc. common stock) granted pursuant to the Zoetis Inc. Amended and Restated 2013 Equity and Incentive Plan. F9 · derivative.exercise_date: One-third of each option will vest on the first, second and third anniversaries of the date of grant, February 6, 2024. F10 · derivative.expiration_date: Each option expires on the tenth anniversary of the date of grant. Read SEC document |
| February 06, 2024 Filed Feb 8, 2024 21:33 UTC | Zoetis Inc. ZTS · Entity 679 | GrantRestricted Stock Unit · Derivative | 1,593 | $0.00 | $0.00 |
DisclosureSEC source: 0001555280-24-000077 · wk-form4_1707428006.xml · derivative · entry 1 Lagano Roxanne · CIK 0001567878 · Executive Vice President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,593 Underlying: Common Stock · 1,593 shares Expires not disclosed F1 · security: Represents restricted stock units granted pursuant to the Zoetis Inc. Amended and Restated 2013 Equity and Incentive Plan, and dividend equivalent units automatically issued thereon (each an "RSU" and collectively, "RSUs"). F2 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of Zoetis Inc. common stock. F3 · derivative.exercise_date: One-third of each RSU will vest and be settled in shares of Zoetis Inc. common stock on the first, second and third anniversaries of the date of grant, February 6, 2024; subject to the reporting person's continued service through such vesting date and subject to earlier vesting and settlement upon certain specific events. F4 · derivative.expiration_date: Not applicable. Read SEC document |
| February 05, 2024 Filed Feb 7, 2024 01:03 UTC | Zoetis Inc. ZTS · Entity 679 | GrantPerformance Award Unit · Derivative | 2,571.9889 | $0.00 | $0.00 |
DisclosureSEC source: 0001555280-24-000042 · wk-form4_1707267801.xml · derivative · entry 1 Lagano Roxanne · CIK 0001567878 · Executive Vice President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,571.9889 Underlying: Common Stock · 2,571.9889 shares Expires not disclosed F1 · security: Represents performance award units with a three-year performance period covering 2021-2023 that were granted pursuant to the Zoetis Inc. 2013 Equity and Incentive Plan, and dividend equivalent units automatically issued thereon. The performance award units reported herein were deemed acquired on February 5, 2024, which is the date the Zoetis Human Resources Committee certified the level of achievement of the applicable performance goal for these performance award units. The performance award units (and dividend equivalent units issued thereon) will vest and be settled in shares of Zoetis common stock on February 10, 2024, subject to the reporting person's continued service through such vesting date and subject to earlier vesting and settlement upon certain specific events. F2 · derivative.exercise_price: Each performance award unit represents a contingent right to receive one share of Zoetis Inc. common stock. F3 · derivative.exercise_date: Each performance award unit will vest and be settled in shares of Zoetis Inc. common stock on February 10, 2024, subject to the reporting person's continued service through such vesting date and subject to earlier vesting and settlement upon certain specific events. F4 · derivative.expiration_date: Not applicable. Read SEC document |
| January 18, 2024 Filed Jan 19, 2024 22:07 UTC | Zoetis Inc. ZTS · Entity 679 | SaleCommon Stock | 923 | $191.43 | $176,689.89 |
DisclosureSEC source: 0001555280-24-000018 · wk-form4_1705702042.xml · nonDerivative · entry 1 Lagano Roxanne · CIK 0001567878 · Executive Vice President 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 17,569 F1 · kind: The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 1, 2023. F2 · price: The Price reported in Table I, Column 4 is the price at which these shares were sold in multiple transactions. Read SEC document |
| January 12, 2024 Filed Jan 17, 2024 21:19 UTC | Zoetis Inc. ZTS · Entity 679 | GrantPhantom Stock Unit · Derivative | 107.7683 | $63.17 | $6,807.72 |
DisclosureSEC source: 0001555280-24-000010 · wk-form4_1705526350.xml · derivative · entry 1 Lagano Roxanne · CIK 0001567878 · Executive Vice President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 25,770.8224 Underlying: Common Stock · 34.22 shares Expires not disclosed F1 · security: These phantom stock units, which were acquired pursuant to the Zoetis Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment fund at any time, provided Zoetis may limit the timing, frequency and permissibility of transfers from one investment fund to another at any time. F2 · derivative.exercise_price: Each phantom stock unit represents a fraction of a phantom share of Zoetis common stock, plus a small amount of cash-equivalent investments (the cash-equivalent investments typically represent around 5% of the total value of the phantom stock unit). Accordingly, the value of each phantom stock unit is determined by reference to the market value of Zoetis common stock and the value of the cash-equivalent investments. F1 · derivative.exercise_date: These phantom stock units, which were acquired pursuant to the Zoetis Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment fund at any time, provided Zoetis may limit the timing, frequency and permissibility of transfers from one investment fund to another at any time. F1 · derivative.expiration_date: These phantom stock units, which were acquired pursuant to the Zoetis Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment fund at any time, provided Zoetis may limit the timing, frequency and permissibility of transfers from one investment fund to another at any time. Read SEC document |
| December 18, 2023 Filed Dec 19, 2023 21:33 UTC | Zoetis Inc. ZTS · Entity 679 | SaleCommon Stock | 923 | $198.14 | $182,883.22 |
DisclosureSEC source: 0001555280-23-000264 · wk-form4_1703021578.xml · nonDerivative · entry 1 Lagano Roxanne · CIK 0001567878 · Executive Vice President 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 18,492 F1 · kind: The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 1, 2023. F2 · price: The Price reported in Table I, Column 4 is the price at which these shares were sold in a single transaction. Read SEC document |
| December 14, 2023 Filed Dec 14, 2023 21:55 UTC | Zoetis Inc. ZTS · Entity 679 | SaleCommon Stock | 2,500 | $200.00 | $500,000.00 |
DisclosureSEC source: 0001555280-23-000262 · wk-form4_1702590910.xml · nonDerivative · entry 1 Lagano Roxanne · CIK 0001567878 · Executive Vice President 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 19,415 F1 · kind: The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 1, 2023. F2 · price: The Price reported in Table I, Column 4 is the price at which these shares were sold in a single transaction. Read SEC document |
| November 29, 2023 Filed Nov 30, 2023 21:34 UTC | Zoetis Inc. ZTS · Entity 679 | GiftCommon Stock | 750 | $0.00 | $0.00 |
DisclosureSEC source: 0001555280-23-000253 · wk-form4_1701380050.xml · nonDerivative · entry 1 Lagano Roxanne · CIK 0001567878 · Executive Vice President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 21,915 F1 · shares: Reflects the gift of common stock to a charitable donor advised fund. F2 · price: Price not applicable to gift. Read SEC document |
| November 17, 2023 Filed Nov 20, 2023 21:45 UTC | Zoetis Inc. ZTS · Entity 679 | SaleCommon Stock | 923 | $177.46 | $163,795.58 |
DisclosureSEC source: 0001555280-23-000249 · wk-form4_1700516741.xml · nonDerivative · entry 1 Lagano Roxanne · CIK 0001567878 · Executive Vice President 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 22,665 F1 · kind: The transaction reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 1, 2023. F2 · price: The Price reported in Table I, Column 4 is the price at which these shares were sold in multiple transactions. Read SEC document |
| October 18, 2023 Filed Oct 19, 2023 20:07 UTC | Zoetis Inc. ZTS · Entity 679 | SaleCommon Stock | 923 | $172.92 | $159,605.16 |
DisclosureSEC source: 0001555280-23-000238 · wk-form4_1697746068.xml · nonDerivative · entry 1 Lagano Roxanne · CIK 0001567878 · Executive Vice President 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 23,588 F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 1, 2023. F2 · price: The Price reported in Table I, Column 4 is the price at which these shares were sold in multiple transactions. Read SEC document |
| October 06, 2023 Filed Oct 10, 2023 20:23 UTC | Zoetis Inc. ZTS · Entity 679 | GrantPhantom Stock Unit · Derivative | 142.0304 | $55.92 | $7,942.34 |
DisclosureSEC source: 0001555280-23-000233 · wk-form4_1696969396.xml · derivative · entry 1 Lagano Roxanne · CIK 0001567878 · Executive Vice President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 25,663.0541 Underlying: Common Stock · 45.2194 shares Expires not disclosed F1 · security: These phantom stock units, which were acquired pursuant to the Zoetis Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment fund at any time, provided Zoetis may limit the timing, frequency and permissibility of transfers from one investment fund to another at any time. F2 · derivative.exercise_price: Each phantom stock unit represents a fraction of a phantom share of Zoetis common stock, plus a small amount of cash-equivalent investments (the cash-equivalent investments typically represent around 5% of the total value of the phantom stock unit). Accordingly, the value of each phantom stock unit is determined by reference to the market value of Zoetis common stock and the value of the cash-equivalent investments. F1 · derivative.exercise_date: These phantom stock units, which were acquired pursuant to the Zoetis Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment fund at any time, provided Zoetis may limit the timing, frequency and permissibility of transfers from one investment fund to another at any time. F1 · derivative.expiration_date: These phantom stock units, which were acquired pursuant to the Zoetis Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment fund at any time, provided Zoetis may limit the timing, frequency and permissibility of transfers from one investment fund to another at any time. Read SEC document |
| September 18, 2023 Filed Sep 18, 2023 20:25 UTC | Zoetis Inc. ZTS · Entity 679 | SaleCommon Stock | 923 | $179.58 | $165,752.34 |
DisclosureSEC source: 0001555280-23-000215 · wk-form4_1695068716.xml · nonDerivative · entry 1 Lagano Roxanne · CIK 0001567878 · Executive Vice President 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 24,511 F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 1, 2023. F2 · price: The Price reported in Table I, Column 4 is the price at which these shares were sold in multiple transactions. Read SEC document |
| September 01, 2023 Filed Sep 5, 2023 21:04 UTC | Zoetis Inc. ZTS · Entity 679 | SaleCommon Stock | 923 | $192.97 | $178,111.31 |
DisclosureSEC source: 0001555280-23-000211 · wk-form4_1693947870.xml · nonDerivative · entry 1 Lagano Roxanne · CIK 0001567878 · Executive Vice President 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 25,434 F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 1, 2023. F2 · price: The Price reported in Table I, Column 4 is the price at which these shares were sold in multiple transactions. Read SEC document |
| July 14, 2023 Filed Jul 18, 2023 21:27 UTC | Zoetis Inc. ZTS · Entity 679 | GrantPhantom Stock Unit · Derivative | 124.3646 | $54.74 | $6,807.72 |
DisclosureSEC source: 0001555280-23-000192 · wk-form4_1689715642.xml · derivative · entry 1 Lagano Roxanne · CIK 0001567878 · Executive Vice President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 25,521.0237 Underlying: Common Stock · 39.5361 shares Expires not disclosed F1 · security: These phantom stock units, which were acquired pursuant to the Zoetis Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment fund at any time, provided Zoetis may limit the timing, frequency and permissibility of transfers from one investment fund to another at any time. F2 · derivative.exercise_price: Each phantom stock unit represents a fraction of a phantom share of Zoetis common stock, plus a small amount of cash-equivalent investments (the cash-equivalent investments typically represent around 5% of the total value of the phantom stock unit). Accordingly, the value of each phantom stock unit is determined by reference to the market value of Zoetis common stock and the value of the cash-equivalent investments. F1 · derivative.exercise_date: These phantom stock units, which were acquired pursuant to the Zoetis Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment fund at any time, provided Zoetis may limit the timing, frequency and permissibility of transfers from one investment fund to another at any time. F1 · derivative.expiration_date: These phantom stock units, which were acquired pursuant to the Zoetis Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment fund at any time, provided Zoetis may limit the timing, frequency and permissibility of transfers from one investment fund to another at any time. Read SEC document |
| April 18, 2023 Filed Apr 19, 2023 20:18 UTC | Zoetis Inc. ZTS · Entity 679 | Exercise / conversionStock Option · Derivative | 2,010 | $0.00 | $0.00 |
DisclosureSEC source: 0001555280-23-000140 · wf-form4_168193548598069.xml · derivative · entry 6 Lagano Roxanne · CIK 0001567878 · Executive Vice President 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 20,221 Underlying: Common Stock · 2,010 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · security: Stock options (right to buy Zoetis Inc. common stock) granted pursuant to the Zoetis Inc. 2013 Equity and Incentive Plan. F9 · derivative.exercise_price: 2,010 options granted on February 12, 2019 at an exercise price of $87.51 per option. F6 · derivative.exercise_date: Each option vests on the third anniversary of the date of grant. F7 · derivative.expiration_date: Each option expires on the tenth anniversary of the date of grant. F10 · balance_after: 7,738 options granted February 11, 2020 at an exercise price of $144.03 per option; 7,106 options granted February 10, 2021 at an exercise price of $160.62 per option; and 5,377 options granted February 8, 2022 at an exercise price of $201.30 per option. Read SEC document |
| April 18, 2023 Filed Apr 19, 2023 20:18 UTC | Zoetis Inc. ZTS · Entity 679 | Exercise / conversionStock Option · Derivative | 2,328 | $0.00 | $0.00 |
DisclosureSEC source: 0001555280-23-000140 · wf-form4_168193548598069.xml · derivative · entry 5 Lagano Roxanne · CIK 0001567878 · Executive Vice President 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 22,231 Underlying: Common Stock · 2,328 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · security: Stock options (right to buy Zoetis Inc. common stock) granted pursuant to the Zoetis Inc. 2013 Equity and Incentive Plan. F5 · derivative.exercise_price: 2,328 options granted February 13, 2018 at an exercise price of $73.24 per option. F6 · derivative.exercise_date: Each option vests on the third anniversary of the date of grant. F7 · derivative.expiration_date: Each option expires on the tenth anniversary of the date of grant. F8 · balance_after: 2,010 options granted February 12, 2019 at an exercise price of $87.51 per option; 7,738 options granted February 11, 2020 at an exercise price of $144.03 per option; 7,106 options granted February 10, 2021 at an exercise price of $160.62 per option; and 5,377 options granted February 8, 2022 at an exercise price of $201.30 per option. Read SEC document |
| April 18, 2023 Filed Apr 19, 2023 20:18 UTC | Zoetis Inc. ZTS · Entity 679 | SaleCommon Stock | 4,338 | $175.94 | $763,227.72 |
DisclosureSEC source: 0001555280-23-000140 · wf-form4_168193548598069.xml · nonDerivative · entry 3 Lagano Roxanne · CIK 0001567878 · Executive Vice President 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 26,357 F2 · price: The Price reported in Table I, Column 4 is the price at which these shares were sold in multiple transactions. Read SEC document |
| April 18, 2023 Filed Apr 19, 2023 20:18 UTC | Zoetis Inc. ZTS · Entity 679 | Exercise / conversionCommon Stock | 2,010 | $87.51 | $175,895.10 |
DisclosureSEC source: 0001555280-23-000140 · wf-form4_168193548598069.xml · nonDerivative · entry 2 Lagano Roxanne · CIK 0001567878 · Executive Vice President 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 30,695 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 25, 2022. Read SEC document |
| April 18, 2023 Filed Apr 19, 2023 20:18 UTC | Zoetis Inc. ZTS · Entity 679 | Exercise / conversionCommon Stock | 2,328 | $73.24 | $170,502.72 |
DisclosureSEC source: 0001555280-23-000140 · wf-form4_168193548598069.xml · nonDerivative · entry 1 Lagano Roxanne · CIK 0001567878 · Executive Vice President 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 28,685 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 25, 2022. Read SEC document |
| April 06, 2023 Filed Apr 10, 2023 20:32 UTC | Zoetis Inc. ZTS · Entity 679 | GrantPhantom Stock Unit · Derivative | 113.9155 | $53.59 | $6,104.73 |
DisclosureSEC source: 0001555280-23-000133 · wf-form4_168115870879540.xml · derivative · entry 1 Lagano Roxanne · CIK 0001567878 · Executive Vice President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 25,396.6591 Underlying: Common Stock · 36.1355 shares Expires not disclosed F1 · security: These phantom stock units, which were acquired pursuant to the Zoetis Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment fund at any time, provided Zoetis may limit the timing, frequency and permissibility of transfers from one investment fund to another at any time. F2 · derivative.exercise_price: Each phantom stock unit represents a fraction of a phantom share of Zoetis common stock, plus a small amount of cash-equivalent investments (the cash-equivalent investments typically represent around 5% of the total value of the phantom stock unit). Accordingly, the value of each phantom stock unit is determined by reference to the market value of Zoetis common stock and the value of the cash-equivalent investments. F1 · derivative.exercise_date: These phantom stock units, which were acquired pursuant to the Zoetis Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment fund at any time, provided Zoetis may limit the timing, frequency and permissibility of transfers from one investment fund to another at any time. F1 · derivative.expiration_date: These phantom stock units, which were acquired pursuant to the Zoetis Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment fund at any time, provided Zoetis may limit the timing, frequency and permissibility of transfers from one investment fund to another at any time. Read SEC document |
| March 31, 2023 Filed Apr 4, 2023 21:14 UTC | Zoetis Inc. ZTS · Entity 679 | GrantPhantom Stock Unit · Derivative | 500.1571 | $52.84 | $26,428.30 |
DisclosureSEC source: 0001555280-23-000121 · wf-form4_168064288631969.xml · derivative · entry 1 Lagano Roxanne · CIK 0001567878 · Executive Vice President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 25,282.7436 Underlying: Common Stock · 158.7858 shares Expires not disclosed F1 · security: These phantom stock units, which were acquired pursuant to the Zoetis Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment fund at any time, provided Zoetis may limit the timing, frequency and permissibility of transfers from one investment fund to another at any time. F2 · derivative.exercise_price: Each phantom stock unit represents a fraction of a phantom share of Zoetis common stock, plus a small amount of cash-equivalent investments (the cash-equivalent investments typically represent around 5% of the total value of the phantom stock unit). Accordingly, the value of each phantom stock unit is determined by reference to the market value of Zoetis common stock and the value of the cash-equivalent investments. F1 · derivative.exercise_date: These phantom stock units, which were acquired pursuant to the Zoetis Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment fund at any time, provided Zoetis may limit the timing, frequency and permissibility of transfers from one investment fund to another at any time. F1 · derivative.expiration_date: These phantom stock units, which were acquired pursuant to the Zoetis Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment fund at any time, provided Zoetis may limit the timing, frequency and permissibility of transfers from one investment fund to another at any time. Read SEC document |
| February 14, 2023 Filed Feb 16, 2023 21:18 UTC | Zoetis Inc. ZTS · Entity 679 | Exercise / conversionStock Option · Derivative | 6,026 | $0.00 | $0.00 |
DisclosureSEC source: 0001555280-23-000108 · wf-form4_167658231320285.xml · derivative · entry 6 Lagano Roxanne · CIK 0001567878 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,559 Underlying: Common Stock · 6,026 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · security: Stock options (right to buy Zoetis Inc. common stock) granted pursuant to the Zoetis Inc. 2013 Equity and Incentive Plan. F9 · derivative.exercise_price: 6,026 options granted on February 12, 2019 at an exercise price of $87.51 per option. F6 · derivative.exercise_date: Each option vests on the third anniversary of the date of grant. F7 · derivative.expiration_date: Each option expires on the tenth anniversary of the date of grant. F10 · balance_after: 2,328 options granted February 13, 2018 at an exercise price of $73.24 per option; 2,010 options granted February 12, 2019 at an exercise price of $87.51 per option; 7,738 options granted February 11, 2020 at an exercise price of $144.03 per option; 7,106 options granted February 10, 2021 at an exercise price of $160.62 per option; and 5,377 options granted February 8, 2022 at an exercise price of $201.30 per option. Read SEC document |
| February 14, 2023 Filed Feb 16, 2023 21:18 UTC | Zoetis Inc. ZTS · Entity 679 | Exercise / conversionStock Option · Derivative | 6,984 | $0.00 | $0.00 |
DisclosureSEC source: 0001555280-23-000108 · wf-form4_167658231320285.xml · derivative · entry 5 Lagano Roxanne · CIK 0001567878 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,585 Underlying: Common Stock · 6,984 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · security: Stock options (right to buy Zoetis Inc. common stock) granted pursuant to the Zoetis Inc. 2013 Equity and Incentive Plan. F5 · derivative.exercise_price: 6,984 options granted February 13, 2018 at an exercise price of $73.24 per option. F6 · derivative.exercise_date: Each option vests on the third anniversary of the date of grant. F7 · derivative.expiration_date: Each option expires on the tenth anniversary of the date of grant. F8 · balance_after: 2,328 options granted February 13, 2018 at an exercise price of $73.24 per option; 8,036 options granted February 12, 2019 at an exercise price of $87.51 per option; 7,738 options granted February 11, 2020 at an exercise price of $144.03 per option; 7,106 options granted February 10, 2021 at an exercise price of $160.62 per option; and 5,377 options granted February 8, 2022 at an exercise price of $201.30 per option. Read SEC document |
| February 14, 2023 Filed Feb 16, 2023 21:18 UTC | Zoetis Inc. ZTS · Entity 679 | SaleCommon Stock | 13,010 | $175.00 | $2,276,750.00 |
DisclosureSEC source: 0001555280-23-000108 · wf-form4_167658231320285.xml · nonDerivative · entry 3 Lagano Roxanne · CIK 0001567878 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,357 F2 · price: The Price reported in Table I, Column 4 is the price at which these shares were sold in multiple transactions. Read SEC document |
| February 14, 2023 Filed Feb 16, 2023 21:18 UTC | Zoetis Inc. ZTS · Entity 679 | Exercise / conversionCommon Stock | 6,026 | $87.51 | $527,335.26 |
DisclosureSEC source: 0001555280-23-000108 · wf-form4_167658231320285.xml · nonDerivative · entry 2 Lagano Roxanne · CIK 0001567878 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 39,367 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 25, 2022. Read SEC document |
| February 14, 2023 Filed Feb 16, 2023 21:18 UTC | Zoetis Inc. ZTS · Entity 679 | Exercise / conversionCommon Stock | 6,984 | $73.24 | $511,508.16 |
DisclosureSEC source: 0001555280-23-000108 · wf-form4_167658231320285.xml · nonDerivative · entry 1 Lagano Roxanne · CIK 0001567878 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 33,341 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 25, 2022. Read SEC document |
| February 11, 2023 Filed Feb 14, 2023 21:52 UTC | Zoetis Inc. ZTS · Entity 679 | Exercise / conversionPerformance Award Unit · Derivative | 2,295.0835 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001555280-23-000097 · wf-form4_167641151630564.xml · derivative · entry 8 Lagano Roxanne · CIK 0001567878 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 2,295.0835 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F9 · security: Performance award units having a three-year performance period covering 2020-2022 previously granted pursuant to the Zoetis Inc. 2013 Equity and Incentive Plan, and dividend equivalent units automatically issued thereon. The performance award units reported herein were deemed acquired on February 8, 2023, which is the date the Zoetis Human Resources Committee certified the level of achievement of the applicable performance goal for these performance award units. The performance award units (and dividend equivalent units issued thereon) vested on February 11, 2023 and were settled in shares of Zoetis common stock. F2 · derivative.exercise_price: Acquisition of common stock upon vesting and settlement of performance award units. Each performance award unit represents a right to receive one share of Zoetis Inc. common stock upon vesting of the performance award unit. F2 · price: Acquisition of common stock upon vesting and settlement of performance award units. Each performance award unit represents a right to receive one share of Zoetis Inc. common stock upon vesting of the performance award unit. F9 · derivative.exercise_date: Performance award units having a three-year performance period covering 2020-2022 previously granted pursuant to the Zoetis Inc. 2013 Equity and Incentive Plan, and dividend equivalent units automatically issued thereon. The performance award units reported herein were deemed acquired on February 8, 2023, which is the date the Zoetis Human Resources Committee certified the level of achievement of the applicable performance goal for these performance award units. The performance award units (and dividend equivalent units issued thereon) vested on February 11, 2023 and were settled in shares of Zoetis common stock. F5 · derivative.expiration_date: Not Applicable. Read SEC document |
| February 11, 2023 Filed Feb 14, 2023 21:52 UTC | Zoetis Inc. ZTS · Entity 679 | Exercise / conversionRestricted Stock Unit · Derivative | 1,857.2114 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001555280-23-000097 · wf-form4_167641151630564.xml · derivative · entry 6 Lagano Roxanne · CIK 0001567878 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,072.6016 Underlying: Common Stock · 1,857.2114 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · security: Restricted stock units previously granted pursuant to the Zoetis Inc. 2013 Equity and Incentive Plan, and dividend equivalent units automatically issued thereon (each an "RSU" and collectively, "RSUs"). The RSUs vest as follows and are settled in Zoetis common stock upon vesting: 1,695.6735 RSUs will vest on February 10, 2024; and 1,376.9281 RSUs will vest on February 8, 2025. F1 · derivative.exercise_price: Acquisition of common stock upon vesting and settlement of restricted stock units (RSUs). Each RSU represents a right to receive one share of Zoetis Inc. common stock upon vesting of the RSU. F1 · price: Acquisition of common stock upon vesting and settlement of restricted stock units (RSUs). Each RSU represents a right to receive one share of Zoetis Inc. common stock upon vesting of the RSU. F4 · derivative.exercise_date: Restricted stock units previously granted pursuant to the Zoetis Inc. 2013 Equity and Incentive Plan, and dividend equivalent units automatically issued thereon (each an "RSU" and collectively, "RSUs"). The RSUs vest as follows and are settled in Zoetis common stock upon vesting: 1,695.6735 RSUs will vest on February 10, 2024; and 1,376.9281 RSUs will vest on February 8, 2025. F5 · derivative.expiration_date: Not Applicable. Read SEC document |
| February 11, 2023 Filed Feb 14, 2023 21:52 UTC | Zoetis Inc. ZTS · Entity 679 | Tax withholdingCommon Stock | 816 | $158.33 | $129,197.28 |
DisclosureSEC source: 0001555280-23-000097 · wf-form4_167641151630564.xml · nonDerivative · entry 4 Lagano Roxanne · CIK 0001567878 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,357 Read SEC document |
| February 11, 2023 Filed Feb 14, 2023 21:52 UTC | Zoetis Inc. ZTS · Entity 679 | Exercise / conversionCommon Stock | 2,295 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001555280-23-000097 · wf-form4_167641151630564.xml · nonDerivative · entry 3 Lagano Roxanne · CIK 0001567878 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,173 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · security: Acquisition of common stock upon vesting and settlement of performance award units. Each performance award unit represents a right to receive one share of Zoetis Inc. common stock upon vesting of the performance award unit. F2 · price: Acquisition of common stock upon vesting and settlement of performance award units. Each performance award unit represents a right to receive one share of Zoetis Inc. common stock upon vesting of the performance award unit. Read SEC document |
| February 11, 2023 Filed Feb 14, 2023 21:52 UTC | Zoetis Inc. ZTS · Entity 679 | Tax withholdingCommon Stock | 666 | $158.33 | $105,447.78 |
DisclosureSEC source: 0001555280-23-000097 · wf-form4_167641151630564.xml · nonDerivative · entry 2 Lagano Roxanne · CIK 0001567878 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,878 Read SEC document |
| February 11, 2023 Filed Feb 14, 2023 21:52 UTC | Zoetis Inc. ZTS · Entity 679 | Exercise / conversionCommon Stock | 1,857 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001555280-23-000097 · wf-form4_167641151630564.xml · nonDerivative · entry 1 Lagano Roxanne · CIK 0001567878 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,544 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: Acquisition of common stock upon vesting and settlement of restricted stock units (RSUs). Each RSU represents a right to receive one share of Zoetis Inc. common stock upon vesting of the RSU. F1 · price: Acquisition of common stock upon vesting and settlement of restricted stock units (RSUs). Each RSU represents a right to receive one share of Zoetis Inc. common stock upon vesting of the RSU. Read SEC document |
| February 08, 2023 Filed Feb 10, 2023 23:28 UTC | Zoetis Inc. ZTS · Entity 679 | GrantStock Option · Derivative | 6,542 | $0.00 Strike: $162.07 | $0.00 |
DisclosureSEC source: 0001555280-23-000058 · wf-form4_167607168523335.xml · derivative · entry 4 Lagano Roxanne · CIK 0001567878 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,542 Underlying: Common Stock · 6,542 shares Expires not disclosed F11 · security: Stock options (right to buy Zoetis Inc. common stock) granted pursuant to the Zoetis Inc. Amended and Restated 2013 Equity and Incentive Plan. F12 · derivative.exercise_date: One-third of each option will vest on the first, second and third anniversaries of the date of grant. F13 · derivative.expiration_date: Each option expires on the tenth anniversary of the date of grant. Read SEC document |
| February 08, 2023 Filed Feb 10, 2023 23:28 UTC | Zoetis Inc. ZTS · Entity 679 | GrantRestricted Stock Unit · Derivative | 1,758 | $0.00 | $0.00 |
DisclosureSEC source: 0001555280-23-000058 · wf-form4_167607168523335.xml · derivative · entry 2 Lagano Roxanne · CIK 0001567878 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,758 Underlying: Common Stock · 1,758 shares Expires not disclosed F5 · security: Represents restricted stock units granted pursuant to the Zoetis Inc. Amended and Restated 2013 Equity and Incentive Plan, and dividend equivalent units automatically issued thereon (each an "RSU" and collectively, "RSUs"). One-third of the RSUs vest and are settled in shares of Zoetis common stock on each of the first, second and third anniversaries of the date of grant, respectively, subject to the reporting person's continued service through such vesting date and subject to earlier vesting and settlement upon certain specific events. F6 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of Zoetis Inc. common stock. F7 · derivative.exercise_date: One-third of each RSU will vest and be settled in shares of Zoetis Inc. common stock on the first, second and third anniversaries of the date of grant, subject to the reporting person's continued service through such vesting date and subject to earlier vesting and settlement upon certain specific events. F4 · derivative.expiration_date: Not applicable. Read SEC document |
| February 08, 2023 Filed Feb 10, 2023 23:28 UTC | Zoetis Inc. ZTS · Entity 679 | GrantPerformance Award Unit · Derivative | 2,295.0835 | $0.00 | $0.00 |
DisclosureSEC source: 0001555280-23-000058 · wf-form4_167607168523335.xml · derivative · entry 1 Lagano Roxanne · CIK 0001567878 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,295.0835 Underlying: Common Stock · 2,295.0835 shares Expires not disclosed F1 · security: Represents performance award units with a three-year performance period covering 2020-2022 that were granted pursuant to the Zoetis Inc. 2013 Equity and Incentive Plan, and dividend equivalent units automatically issued thereon. The performance award units reported herein were deemed acquired on February 8, 2023, which is the date the Zoetis Human Resources Committee certified the level of achievement of the applicable performance goal for these performance award units. The performance award units (and dividend equivalent units issued thereon) will vest and be settled in shares of Zoetis common stock on February 11, 2023, subject to the reporting person's continued service through such vesting date and subject to earlier vesting and settlement upon certain specific events. F2 · derivative.exercise_price: Each performance award unit represents a contingent right to receive one share of Zoetis Inc. common stock. F3 · derivative.exercise_date: Each performance award unit will vest and be settled in shares of Zoetis Inc. common stock on February 11, 2023 subject to the reporting person's continued service through such vesting date and subject to earlier vesting and settlement upon certain specific events. F4 · derivative.expiration_date: Not applicable. Read SEC document |
| January 13, 2023 Filed Jan 18, 2023 21:29 UTC | Zoetis Inc. ZTS · Entity 679 | GrantPhantom Stock Unit · Derivative | 130.0396 | $51.02 | $6,634.62 |
DisclosureSEC source: 0001555280-23-000016 · wf-form4_167407737911782.xml · derivative · entry 1 Lagano Roxanne · CIK 0001567878 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,782.5866 Underlying: Common Stock · 7,857.3674 shares Expires not disclosed F1 · security: These phantom stock units, which were acquired pursuant to the Zoetis Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment fund at any time, provided Zoetis may limit the timing, frequency and permissibility of transfers from one investment fund to another at any time. F2 · derivative.exercise_price: Each phantom stock unit represents a fraction of a phantom share of Zoetis common stock, plus a small amount of cash-equivalent investments (the cash-equivalent investments typically represent around 5% of the total value of the phantom stock unit). Accordingly, the value of each phantom stock unit is determined by reference to the market value of Zoetis common stock and the value of the cash-equivalent investments. F1 · derivative.exercise_date: These phantom stock units, which were acquired pursuant to the Zoetis Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment fund at any time, provided Zoetis may limit the timing, frequency and permissibility of transfers from one investment fund to another at any time. F1 · derivative.expiration_date: These phantom stock units, which were acquired pursuant to the Zoetis Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment fund at any time, provided Zoetis may limit the timing, frequency and permissibility of transfers from one investment fund to another at any time. Read SEC document |
| October 07, 2022 Filed Oct 11, 2022 20:37 UTC | Zoetis Inc. ZTS · Entity 679 | GrantPhantom Stock Unit · Derivative | 165.5345 | $46.76 | $7,740.39 |
DisclosureSEC source: 0001555280-22-000255 · wf-form4_166552064870042.xml · derivative · entry 1 Lagano Roxanne · CIK 0001567878 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,652.547 Underlying: Common Stock · 7,822.1693 shares Expires not disclosed F1 · security: These phantom stock units, which were acquired pursuant to the Zoetis Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment fund at any time, provided Zoetis may limit the timing, frequency and permissibility of transfers from one investment fund to another at any time. F2 · derivative.exercise_price: Each phantom stock unit represents a fraction of a phantom share of Zoetis common stock, plus a small amount of cash-equivalent investments (the cash-equivalent investments typically represent around 5% of the total value of the phantom stock unit). Accordingly, the value of each phantom stock unit is determined by reference to the market value of Zoetis common stock and the value of the cash-equivalent investments. F1 · derivative.exercise_date: These phantom stock units, which were acquired pursuant to the Zoetis Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment fund at any time, provided Zoetis may limit the timing, frequency and permissibility of transfers from one investment fund to another at any time. F1 · derivative.expiration_date: These phantom stock units, which were acquired pursuant to the Zoetis Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment fund at any time, provided Zoetis may limit the timing, frequency and permissibility of transfers from one investment fund to another at any time. Read SEC document |
| July 22, 2022 Filed Jul 26, 2022 20:36 UTC | Zoetis Inc. ZTS · Entity 679 | Exercise / conversionStock Option · Derivative | 1,004 | $0.00 | $0.00 |
DisclosureSEC source: 0001555280-22-000221 · wf-form4_165886778126391.xml · derivative · entry 5 Lagano Roxanne · CIK 0001567878 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 37,569 Underlying: Common Stock · 1,004 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · security: Stock options (right to buy Zoetis Inc. common stock) granted pursuant to the Zoetis Inc. 2013 Equity and Incentive Plan. F8 · derivative.exercise_price: 1,004 options granted February 12, 2019 at an exercise price of $87.51 per option. F5 · derivative.exercise_date: Each option vests on the third anniversary of the date of grant. F6 · derivative.expiration_date: Each option expires on the tenth anniversary of the date of grant. F9 · balance_after: 9,312 options granted February 13, 2018 at an exercise price of $73.24 per option; 8,036 options granted February 12, 2019 at an exercise price of $87.51 per option; 7,738 options granted February 11, 2020 at an exercise price of $144.03 per option; 7,106 options granted February 10, 2021 at an exercise price of $160.62 per option; and 5,377 options granted February 8, 2022 at an exercise price of $201.30 per option. Read SEC document |
| July 22, 2022 Filed Jul 26, 2022 20:36 UTC | Zoetis Inc. ZTS · Entity 679 | Exercise / conversionStock Option · Derivative | 1,163 | $0.00 | $0.00 |
DisclosureSEC source: 0001555280-22-000221 · wf-form4_165886778126391.xml · derivative · entry 4 Lagano Roxanne · CIK 0001567878 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 38,573 Underlying: Common Stock · 1,163 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · security: Stock options (right to buy Zoetis Inc. common stock) granted pursuant to the Zoetis Inc. 2013 Equity and Incentive Plan. F4 · derivative.exercise_price: 1,163 options granted February 13, 2018 at an exercise price of $73.24 per option. F5 · derivative.exercise_date: Each option vests on the third anniversary of the date of grant. F6 · derivative.expiration_date: Each option expires on the tenth anniversary of the date of grant. F7 · balance_after: 9,312 options granted February 13, 2018 at an exercise price of $73.24 per option; 9,040 options granted February 12, 2019 at an exercise price of $87.51 per option; 7,738 options granted February 11, 2020 at an exercise price of $144.03 per option; 7,106 options granted February 10, 2021 at an exercise price of $160.62 per option; and 5,377 options granted February 8, 2022 at an exercise price of $201.30 per option. Read SEC document |
| July 22, 2022 Filed Jul 26, 2022 20:36 UTC | Zoetis Inc. ZTS · Entity 679 | SaleCommon Stock | 2,167 | $180.26 | $390,623.42 |
DisclosureSEC source: 0001555280-22-000221 · wf-form4_165886778126391.xml · nonDerivative · entry 3 Lagano Roxanne · CIK 0001567878 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,687 F2 · price: The Price reported in Table I, Column 4 is the price at which these shares were sold in multiple transactions. Read SEC document |
| July 22, 2022 Filed Jul 26, 2022 20:36 UTC | Zoetis Inc. ZTS · Entity 679 | Exercise / conversionCommon Stock | 1,004 | $87.51 | $87,860.04 |
DisclosureSEC source: 0001555280-22-000221 · wf-form4_165886778126391.xml · nonDerivative · entry 2 Lagano Roxanne · CIK 0001567878 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,854 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| July 22, 2022 Filed Jul 26, 2022 20:36 UTC | Zoetis Inc. ZTS · Entity 679 | Exercise / conversionCommon Stock | 1,163 | $73.24 | $85,178.12 |
DisclosureSEC source: 0001555280-22-000221 · wf-form4_165886778126391.xml · nonDerivative · entry 1 Lagano Roxanne · CIK 0001567878 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,850 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 25, 2022. Read SEC document |
| July 15, 2022 Filed Jul 19, 2022 21:17 UTC | Zoetis Inc. ZTS · Entity 679 | GrantPhantom Stock Unit · Derivative | 141.2996 | $54.78 | $7,740.39 |
DisclosureSEC source: 0001555280-22-000215 · wf-form4_165826543681590.xml · derivative · entry 1 Lagano Roxanne · CIK 0001567878 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,487.0125 Underlying: Common Stock · 7,685.336 shares Expires not disclosed F1 · security: These phantom stock units, which were acquired pursuant to the Zoetis Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment fund at any time, provided Zoetis may limit the timing, frequency and permissibility of transfers from one investment fund to another at any time. F2 · derivative.exercise_price: Each phantom stock unit represents a fraction of a phantom share of Zoetis common stock, plus a small amount of cash-equivalent investments (the cash-equivalent investments typically represent around 5% of the total value of the phantom stock unit). Accordingly, the value of each phantom stock unit is determined by reference to the market value of Zoetis common stock and the value of the cash-equivalent investments. F1 · derivative.exercise_date: These phantom stock units, which were acquired pursuant to the Zoetis Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment fund at any time, provided Zoetis may limit the timing, frequency and permissibility of transfers from one investment fund to another at any time. F1 · derivative.expiration_date: These phantom stock units, which were acquired pursuant to the Zoetis Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment fund at any time, provided Zoetis may limit the timing, frequency and permissibility of transfers from one investment fund to another at any time. Read SEC document |
| June 27, 2022 Filed Jun 28, 2022 21:29 UTC | Zoetis Inc. ZTS · Entity 679 | Exercise / conversionStock Option · Derivative | 2,008 | $0.00 | $0.00 |
DisclosureSEC source: 0001555280-22-000193 · wf-form4_165645175114067.xml · derivative · entry 5 Lagano Roxanne · CIK 0001567878 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 39,736 Underlying: Common Stock · 2,008 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · security: Stock options (right to buy Zoetis Inc. common stock) granted pursuant to the Zoetis Inc. 2013 Equity and Incentive Plan. F8 · derivative.exercise_price: 2,008 options granted February 12, 2019 at an exercise price of $87.51 per option. F5 · derivative.exercise_date: Each option vests on the third anniversary of the date of grant. F6 · derivative.expiration_date: Each option expires on the tenth anniversary of the date of grant. F9 · balance_after: 10,475 options granted February 13, 2018 at an exercise price of $73.24 per option; 9,040 options granted February 12, 2019 at an exercise price of $87.51 per option; 7,738 options granted February 11, 2020 at an exercise price of $144.03 per option; 7,106 options granted February 10, 2021 at an exercise price of $160.62 per option; and 5,377 options granted February 8, 2022 at an exercise price of $201.30 per option. Read SEC document |
| June 27, 2022 Filed Jun 28, 2022 21:29 UTC | Zoetis Inc. ZTS · Entity 679 | Exercise / conversionStock Option · Derivative | 2,326 | $0.00 | $0.00 |
DisclosureSEC source: 0001555280-22-000193 · wf-form4_165645175114067.xml · derivative · entry 4 Lagano Roxanne · CIK 0001567878 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 41,744 Underlying: Common Stock · 2,326 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · security: Stock options (right to buy Zoetis Inc. common stock) granted pursuant to the Zoetis Inc. 2013 Equity and Incentive Plan. F4 · derivative.exercise_price: 2,326 options granted February 13, 2018 at an exercise price of $73.24 per option. F5 · derivative.exercise_date: Each option vests on the third anniversary of the date of grant. F6 · derivative.expiration_date: Each option expires on the tenth anniversary of the date of grant. F7 · balance_after: 10,475 options granted February 13, 2018 at an exercise price of $73.24 per option; 11,048 options granted February 12, 2019 at an exercise price of $87.51 per option; 7,738 options granted February 11, 2020 at an exercise price of $144.03 per option; 7,106 options granted February 10, 2021 at an exercise price of $160.62 per option; and 5,377 options granted February 8, 2022 at an exercise price of $201.30 per option. Read SEC document |
| June 27, 2022 Filed Jun 28, 2022 21:29 UTC | Zoetis Inc. ZTS · Entity 679 | SaleCommon Stock | 4,334 | $175.00 | $758,450.00 |
DisclosureSEC source: 0001555280-22-000193 · wf-form4_165645175114067.xml · nonDerivative · entry 3 Lagano Roxanne · CIK 0001567878 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,687 F2 · price: The Price reported in Table I, Column 4 is the price at which these shares were sold in multiple transactions. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.